Lung Ultrasound Aids Early Delirium Detection in Resource-Limited Settings: Study

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-07-15 15:30 GMT   |   Update On 2025-07-15 15:30 GMT
Advertisement

Researchers have found in a new study that Delirium may be better managed through routine use of lung ultrasound (LUS), especially in low-resource settings. A LUS score >3 combined with a low MMSE can help identify high-risk patients early, allowing timely preventive interventions. However further research is needed to validate these findings and explore underlying mechanisms. The study was published in the Archives of Gerontology and Geriatrics Plus by Thomas F. and colleagues.

Delirium, as a rapid onset of disorientation and confusion, is also common in hospitalized elderly with COVID-19 and reflects poor outcomes. Yet it is underdiagnosed, as its symptoms overlap with dementia and other cognitive disorders. In response to this diagnostic issue, a recent study at San Luigi Hospital sought to assess whether LUS abnormalities and cognitive screening could be useful tools for the early prediction of delirium.

We recruited 64 hospitalized patients with COVID-19 with a mean age of 82.6 years in this prospective observational study. All patients received a lung ultrasound to determine the LUS Extension Score (LUSext) for the extent of lung involvement. Cognitive performance was measured with the Mini-Mental State Examination (MMSE) and the 4AT test for delirium assessment. Apart from these, the investigators also gathered extensive clinical information, such as comorbidities and inflammatory markers. Statistical analysis included ROC curves and multivariate logistic regression to determine factors that were independently related to delirium.

Key Findings

Delirium was seen in 61.4% of the patients (35 out of 57 evaluable cases). Univariate analysis showed a significant correlation with several factors:

  • Pre-existing dementia (p = 0.03)

  • Increased LUSext scores (p = 0.004)

  • Decreased MMSE scores (p = 0.0002)

  • ROC curve analysis indicated that a LUSext score >3 was associated with 74% sensitivity and 82% specificity to predict delirium.

  • On multivariate logistic regression, LUS score >3 was a persistent, independent predictor of delirium (Odds Ratio [OR] = 4.22, p = 0.023).

  • For every point reduction in MMSE score, the odds of developing delirium increased (OR = 0.87, p = 0.007).

This analysis concludes that both high LUSext scores (>3) and low MMSE scores are independent and clinically useful predictors of delirium in older COVID-19 patients. Adding lung ultrasound and cognitive screening to routine hospital evaluations, clinicians can potentially improve earlier detection and preventive treatment for those at highest risk. Additional studies are needed to validate these findings and identify mechanisms underlying delirium in this high-risk population.

Reference:

Fraccalini, T., Bergoglio, I. R., Fonte, G., Trogolo, A., Maraschi, A., Roberts, T., Tarozzo, B., Vitorino, B., Vecchini, J. M., Mariangela, S., Traversa, M., Crea, T., Cardinale, L., Maina, G., Ricci, V., Binello, E., Turja, R., Mallamaci, F., & Volpicelli, G. (2025). Lung ultrasound (LUS) as a predictor of delirium in elderly patients with COVID-19 during hospitalization: A geriatric vulnerability-stress model. Archives of Gerontology and Geriatrics Plus, 2(3), 100186. https://doi.org/10.1016/j.aggp.2025.100186


Tags:    
Article Source : Archives of Gerontology and Geriatrics

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News